AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adult patients with advanced solid tumors

被引：0
|
作者：
Mita, A. C.
Wang, D.
Takimoto, C. H.
Malseed, E.
Nguyen, L.
Rasmussen, E.
Storgard, C.
LoRusso, P.
机构：
[1] Inst Drug Dev, San Antonio, TX USA
[2] Wayne State Karmanos Canc Inst, Detroit, MI USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14033
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
    Thein, Kyaw Z.
    Piha-Paul, Sarina A.
    Tsimberidou, Apostolia
    Karp, Daniel D.
    Janku, Filip
    Fu, Siqing
    Subbiah, Vivek
    Hong, David S.
    Yap, Timothy A.
    Shah, Jatin
    Milton, Denai R.
    McQuinn, Lacey
    Gong, Jing
    Tran, Yanyan
    Carter, Brett W.
    Colen, Rivka
    Meric-Bernstam, Funda
    Naing, Aung
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [32] A first-in-human study of AMG 780, an angiopoietin-1 and-2 (ANG1/2) inhibitor, in patients (pts) with advanced solid tumors.
    Dowlati, Afshin
    Vlahovic, Gordana
    Natale, Ronald B.
    Rasmussen, Erik
    Singh, Indrajeet
    Hwang, Yuying C.
    Rossi, John
    Bass, Michael
    Friberg, Gregory R.
    Pickett-Gies, Cheryl Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] First-in-human study of AMG 337, a highly selective oral inhibitor of MET, in adult patients (pts) with advanced solid tumors
    Hong, David S.
    LoRusso, Patricia
    Hamid, Omid
    Beaupre, Darrin M.
    Janku, Filip
    Khan, Rabla
    Kittaneh, Mualad
    Loberg, Robert D.
    Amore, Benny
    Caudillo, Isaac
    Hwang, Yuying C.
    Tang, Rui
    Mgarmchamnanrith, Gataree
    Kwak, Eunice Leo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors
    Yasui, Hirofumi
    Go, Ning
    Yang, Hui
    Amore, Benny M.
    Jung, A. Scott
    Doi, Toshihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (08) : 772 - 776
  • [35] A phase 1 study of MEDI3617, a selective angiopoietin-2 inhibitor, alone and in combination with carboplatin/paclitaxel, paclitaxel, or bevacizmab in patients with advanced solid tumors.
    Hyman, David Michael
    Rizvi, Naiyer A.
    Natale, Ronald B.
    Armstrong, Deborah Kay
    Birrer, Michael J.
    Recht, Lawrence David
    Dotan, Efrat
    Gribbin, Matthew Joseph
    McDevitt, Jennifer T.
    Tavakkoli, Fatemeh
    McCaffrey, Jennifer
    Sikorski, Robert
    Lai, Dominic W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors
    Hong, David S.
    Rosen, Peter
    Lockhart, A. Craig
    Fu, Siqing
    Janku, Filip
    Kurzrock, Razelle
    Khan, Rabia
    Amore, Benny
    Caudillo, Isaac
    Deng, Hongjie
    Hwang, Yuying C.
    Loberg, Robert
    Ngarmchamnanrith, Gataree
    Beaupre, Darrin M.
    Lee, Peter
    ONCOTARGET, 2015, 6 (21) : 18693 - 18706
  • [37] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
    Maguire, William F.
    Schmitz, John C.
    Scemama, Jonas
    Czambel, Ken
    Lin, Yan
    Green, Anthony G.
    Wu, Shaoyu
    Lin, Huang
    Puhalla, Shannon
    Rhee, John
    Stoller, Ronald
    Tawbi, Hussein
    Lee, James J.
    Wright, John J.
    Beumer, Jan H.
    Chu, Edward
    Appleman, Leonard J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (04) : 643 - 654
  • [38] Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors
    William F. Maguire
    John C. Schmitz
    Jonas Scemama
    Ken Czambel
    Yan Lin
    Anthony G. Green
    Shaoyu Wu
    Huang Lin
    Shannon Puhalla
    John Rhee
    Ronald Stoller
    Hussein Tawbi
    James J. Lee
    John J. Wright
    Jan H. Beumer
    Edward Chu
    Leonard J. Appleman
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 643 - 654
  • [39] First-in-human study of AMG 208, an oral MET inhibitor, in adult patients (pts) with advanced solid tumors
    Hong, David S.
    Rosen, Peter J.
    Lockhart, A. Craig
    Fu, Siqing
    Janku, Filip
    Kurzrock, Razelle
    Khan, Rabia
    Amore, Benny
    Caudillo, Isaac
    Deng, Hongjie
    Hwang, Yuying C.
    Loberg, Robert D.
    Shubhakar, Poornima
    Zoog, Stephen
    Beaupre, Darrin M.
    Lee, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [40] Trial in progress: Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors
    Kummar, Shivaani
    Barve, Minal
    Feldman, Eric
    Ma, Seunghyun
    Merchan, Jaime
    Im, Seock-Ah
    Rha, Sun Young
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345